Published in Hypertension on December 01, 2000
Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion. PLoS Genet (2005) 2.33
Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites. Hypertension (2013) 2.13
Elderly blacks have a blunted sympathetic neural responsiveness but greater pressor response to orthostasis than elderly whites. Hypertension (2012) 1.63
G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension (2009) 1.62
Ethnic differences in resting heart rate variability: a systematic review and meta-analysis. Psychosom Med (2015) 1.31
Adiposity and human regional body temperature. Am J Clin Nutr (2009) 1.12
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant (2014) 1.07
Vestibulosympathetic reflex during the early follicular and midluteal phases of the menstrual cycle. Am J Physiol Endocrinol Metab (2008) 1.06
Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension (2010) 0.94
Racial differences in nitric oxide-dependent vasorelaxation. Reprod Sci (2008) 0.92
Postprandial endothelial function does not differ in women by race: an insulin resistance paradox? Am J Physiol Endocrinol Metab (2011) 0.88
The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology. Arch Med Sci (2012) 0.87
Carotid baroreflex responsiveness is impaired in normotensive African American men. Am J Physiol Heart Circ Physiol (2011) 0.87
Alpha-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults. Psychophysiology (2011) 0.86
Microneurographic research in women. Front Physiol (2012) 0.86
The effect of ethnicity on the vascular responses to cold exposure of the extremities. Eur J Appl Physiol (2014) 0.81
Racial differences in heart rate variability during sleep in women: the study of women across the nation sleep study. Psychosom Med (2013) 0.81
Effect of resistance training on biomarkers of vascular function and oxidative stress in young African-American and Caucasian men. J Hum Hypertens (2012) 0.81
Influence of education and neighborhood poverty on pressor responses to phenylephrine in African-Americans and Caucasian-Americans. Biol Psychol (2009) 0.81
Sympathetic Neural and Hemodynamic Responses During Cold Pressor Test in Elderly Blacks and Whites. Hypertension (2016) 0.77
Relationship between waking-sleep blood pressure and catecholamine changes in African-American and European-American women. Blood Press Monit (2008) 0.77
Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study. J Hum Hypertens (2015) 0.77
Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction. Pharmacogenomics J (2014) 0.76
Comparison of brachial artery vasoreactivity in elite power athletes and age-matched controls. PLoS One (2013) 0.76
Aerobic Exercise Training and Arterial Changes in African Americans versus Caucasians. Med Sci Sports Exerc (2016) 0.75
GENETIC VARIATION IN THE β(2)-ADRENERGIC RECEPTOR: IMPACT ON INTERMEDIATE CARDIOVASCULAR PHENOTYPES. Curr Pharmacogenomics Person Med (2008) 0.75
Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women. Appl Physiol Nutr Metab (2016) 0.75
Genetic variation in the alpha1B-adrenergic receptor and vascular response. Pharmacogenomics J (2016) 0.75
Differential Post-Exercise Blood Pressure Responses between Blacks and Caucasians. PLoS One (2016) 0.75
Interethnic differences at the thermometric response to cold test: functional disorders of blood circulation in hand fingers and exposure to hand-arm vibration. Int Arch Occup Environ Health (2007) 0.75
QT dispersion and sudden unexpected death in chronic heart failure. Lancet (1994) 4.17
Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med (1981) 3.98
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest (1998) 3.66
Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med (1995) 3.25
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Some properties of purified skeletal muscle alpha-actinin. J Biol Chem (1976) 3.06
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Racial differences in the response to drugs--pointers to genetic differences. N Engl J Med (2001) 2.90
Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol (2001) 2.86
Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther (1979) 2.85
Acute mountain sickness. N Engl J Med (1969) 2.84
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med (2001) 2.74
The Dehydrogenation of Alcohols by Streptococci of Group B. J Bacteriol (1942) 2.46
Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest (1997) 2.44
The effect of the interaction of ions, drugs and electrical stimulation as indicated by contraction of the anterior retractor of the byssus of mytilus edulis. J Physiol (1938) 2.38
Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J (1994) 2.32
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling. Clin Pharmacol Ther (1979) 2.31
Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med (1989) 2.29
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res (1999) 2.24
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther (2010) 2.22
Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction. JAMA (1995) 2.18
Compound composite odontome associated with an unerupted deciduous incisor--a rarity. J Indian Soc Pedod Prev Dent (2005) 2.05
Asymmetry in muscle weight and one-sided dominance in the human lower limbs. J Anat (1970) 1.95
Factors affecting the sodium, potassium and total base content of the anterior retractor of the byssus of mytilus edulis. J Physiol (1938) 1.93
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
Rickettsial diseases in Haryana: not an uncommon entity. J Assoc Physicians India (2009) 1.85
Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol (1984) 1.83
Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75
Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A (1984) 1.75
Functional asymmetry in the lower limbs. Acta Anat (Basel) (1970) 1.71
The architecture of cancellous bone. J Anat (1978) 1.66
Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol (1977) 1.64
Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation (1999) 1.63
Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol (1975) 1.63
Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther (1979) 1.62
Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol (1978) 1.60
Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther (2000) 1.60
Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol (2001) 1.59
A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification. Heart (2009) 1.59
Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study. Int J Tuberc Lung Dis (2004) 1.58
Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res (1985) 1.56
The Boarders in the Emergency Department (BED) study. Emerg Med J (2008) 1.56
The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. N Engl J Med (1984) 1.56
Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. BMJ (2011) 1.55
HLA in human serum--quantitation of class I by enzyme immunoassay. Transplantation (1992) 1.55
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther (1979) 1.55
Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study. Diabetologia (2010) 1.54
Isotonic extension and shortening of the anterior retractor of the byssus of mytilus edulis. J Physiol (1938) 1.53
Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem (1996) 1.51
Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters. Biochem J (1999) 1.51
Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol (1998) 1.51
Retracted Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through EDG-2 receptors. J Biol Chem (2000) 1.48
Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction. Biochim Biophys Acta (1999) 1.47
Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance. Anesthesiology (1992) 1.46
Down's syndrome, dementia, and superoxide dismutase. Br J Psychiatry (1993) 1.45
Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med (1982) 1.43
Propranolol withdrawal syndrome - why? Circulation (1978) 1.43
CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism. Clin Pharmacol Ther (2000) 1.42
SPECT in adult mosaic Down's syndrome with early dementia. Clin Nucl Med (1994) 1.40
Bacterial pneumonias--evaluation of various sputum culture methods. J Postgrad Med (1994) 1.40
Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J (1982) 1.39
The effect of mivacurium pretreatment on intra-ocular pressure changes induced by suxamethonium. Anaesthesia (1998) 1.39
Raised plasma concentrations of brain natriuretic peptide in pulmonary arterial hypertension. Respir Med (1995) 1.39
Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther (1991) 1.39
Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem (1998) 1.39
Delirium in the elderly. Br J Hosp Med (Lond) (2005) 1.38
Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res (2001) 1.37
Biological determinants of propranolol disposition in man. Clin Pharmacol Ther (1978) 1.35
Short stature and chronic renal failure: what concerns children and parents? Arch Dis Child (1995) 1.34
Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. Pharmacogenetics (1999) 1.33
Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin Pharmacol Ther (1999) 1.32
Mechanisms of virus uncoating. Trends Microbiol (1994) 1.32
One-sided dominance in the limbs of rabbits and frogs, as evidenced by asymmetry in bone weight. J Anat (1971) 1.32
Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation (1997) 1.31
Exacerbation of vasotonic angina pectoris by propranolol. Circulation (1982) 1.31
Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther (1981) 1.30
Thrombotic thrombocytopenic purpura and clopidogrel--a need for new approaches to drug safety. N Engl J Med (2000) 1.30
Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics (2001) 1.28
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration. Clin Pharmacokinet (1979) 1.28
Lovastatin for X-linked adrenoleukodystrophy. N Engl J Med (1998) 1.27
Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci U S A (1988) 1.26
Asymmetry in bone weight in the human lower limbs. Anat Anz (1971) 1.25
N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med (1998) 1.25
Tolbutamide in cirrhosis of the liver. Lancet (1961) 1.24
Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J Biol Chem (1999) 1.23
Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest (1981) 1.23
Recruiting patients to clinical trials: lessons from studies of growth hormone treatment in renal failure. Arch Dis Child (1995) 1.22
Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res (1984) 1.21
Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med (1984) 1.21
Blood coagulation changes at high altitude predisposing to pulmonary hypertension. Br Heart J (1972) 1.19
Some qualitative and quantitative aspects of the intestinal microflora of the glaucous-winged gull (Larus glaucescens). Can J Microbiol (1972) 1.18
Trace metal concentration in different Indian tobacco products and related health implications. Food Chem Toxicol (2010) 1.18
Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Clin Pharmacol Ther (1997) 1.17
Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem (1997) 1.17
Asymmetry in bone weight in the human upper limbs. Anat Anz (1970) 1.16
Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am J Physiol (1996) 1.16
Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J Lipid Res (2006) 1.14